How Skincare Borrowed the Word Peptide

Walk the length of any skincare counter and count the word. It is on the small heavy bottle kept behind glass and on the tube stacked by the till, on things costing more than a week's shopping and on things costing less than a sandwich — and in almost no case does the front of the pack say which peptide, at what concentration, or on what evidence. Do they do anything? The fair answer is: some of them, probably, a little. Several have measurable effects on skin cells in culture, and a handful have small human studies reporting modest changes in how skin looks. But the word itself is not the evidence for any of that. It names a class of chemistry so broad it sits nearer to "protein" than to an ingredient, and a jar can carry it truthfully whether the molecule inside is a studied one at a studied level or a trace of something nobody has tested.

A word that names a size, not a job

A peptide is a short chain of amino acids strung together by the same bond that builds every protein in the body. The only thing separating the two words is length — somewhere around fifty residues, by convention rather than any law of nature, a peptide has become a protein. Insulin is a peptide. So is the compound in a serum priced like jewellery, and so is the one in the tube by the till.

That is an unusual thing for a marketing term to be. Most ingredient words on a pack narrow something down: "retinoid" names a family sharing a mechanism, a sun protection factor is a number from a standardised test. "Peptide" narrows nothing, being true of thousands of molecules with nothing in common but how they are built — which is what makes it serviceable on a label. It has the cadence of an active ingredient while naming an entire class of chemistry, and the reader hears the first.

What is genuinely underneath

None of this was invented out of nothing, and the laboratory work deserves stating first and stating fairly. Several distinct families of short peptide have been proposed as active on skin biology, each with reasoning coherent enough that it is easy to see why the category caught on 1.

The first are the signal peptides, and the idea rests on a real feature of connective tissue. When collagen in the dermis breaks down, fragments of it are released, and fibroblasts — the cells that manufacture the matrix skin is built from — appear to read those fragments as evidence of damage and step up synthesis in response. If the fragment is the message, the reasoning goes, you can supply the message without the damage. Short peptides resembling pieces of collagen have been made and tested in culture on exactly that premise 1.

The second family are the copper carriers, best known among them a tripeptide that binds copper tightly and is usually studied as the copper complex rather than the bare peptide. Copper is required by the enzymes that cross-link collagen and elastin into load-bearing fibres, so a small molecule that can hold and hand over the ion arrives with a mechanism already attached. The cell-culture literature here is substantial by cosmetic-ingredient standards 3.

The third family are the neurotransmitter-inhibiting peptides, modelled loosely on botulinum toxin. The toxin stops nerve endings releasing their chemical signal, so the muscle they serve does not contract; certain short peptides interfere with the same protein machinery in cell systems, and are sold on the analogy 1. Whether such a peptide, applied to the surface, ever reaches a nerve terminal in living tissue is a separate question worth keeping hold of.

So the gap here is not between a claim and nothing at all. It is between a claim and how much — harder to see, and much harder to put on a label.

The sentence a cosmetic is not allowed to write

Here is the part that explains the entire category, and it has almost nothing to do with peptides. Regulatory systems across the UK, the European Union and the United States define a cosmetic by what it is intended to do: cleanse, perfume, protect, keep in good condition, change appearance. A product intended to affect the structure or any function of the body is not a cosmetic at all. It is a medicine, and needs approval — a dossier, controlled trials, years of review, money on a scale a skincare launch does not contemplate.

Now imagine a company that genuinely believes its peptide increases collagen synthesis in the dermis. Increasing collagen synthesis is, unambiguously, altering the structure of the body. Print it on the carton and the product has claimed a drug effect and reclassified itself into a regime it cannot survive. So the carton says something else. Skin "looks firmer". The "appearance of fine lines" is "visibly reduced". The formula "helps support" the skin's "natural renewal". Every one of those describes how something looks and stops carefully short of what is happening in the tissue.

This is why cosmetic copy reads as evasive. It is not evasive; it is compliant. The vagueness is engineered, and the engineer is the regulator rather than the copywriter. Once seen it cannot be unseen — every hedge on every pack in the aisle is a boundary marker, set exactly where the line between a cosmetic and a medicine falls.

The barrier is doing its job

Whatever a molecule is proposed to do, it first has to arrive. The outermost layer of skin, the stratum corneum, is a sheet of dead flattened cells set in lipid — usually described as bricks in mortar, and about as accommodating. Its entire purpose is exclusion: holding water in and keeping everything else out. It is very good at this, which is the only reason any of us can sit in a bath.

Peptides are poor candidates for getting through. They are water-loving where the barrier is greasy, frequently carry charge, and are often larger than the few-hundred-dalton range that crosses intact skin with any ease. A peptide with genuine activity on fibroblasts still has to reach fibroblasts, which live in the dermis. The mechanism can be immaculate and entirely irrelevant if the molecule stops at the surface.

The useful thing here is that this is not a matter of opinion. Excised human skin can be mounted in a diffusion cell, a compound applied on top, then the skin separated layer by layer and each layer assayed for how much is actually in it. A copper tripeptide has been examined precisely this way, the recovered amounts differing sharply between the surface layer, the epidermis beneath and the dermis below that 4. The numbers matter less than the shape of the finding: penetration is limited, and strongly layer-dependent.

This is the question almost every product claim steps around. Naming an ingredient asserts presence in the jar. It says nothing about what fraction reaches the cells the story is about — and that fraction is the whole difference between an interesting molecule and an effective product.

What the trials actually measure

There is a clinical literature on topical peptides, and it is worth characterising honestly rather than dismissing 2. The typical study enrols a few dozen participants, runs eight to twelve weeks, and is funded or conducted by the company supplying the ingredient. The endpoints are instrumental or photographic: wrinkle depth from a silicone impression or optical profile, elasticity from a small suction probe, hydration from an electrical measurement at the surface, and graded before-and-after photographs scored by a trained assessor 23.

Those are entirely legitimate endpoints for a cosmetic. Since the only claim the product may make concerns appearance, appearance is the correct thing to measure; it would be perverse to demand a biopsy in support of a sentence about looking smoother.

They are also weak evidence for the biology implied around them. A reduction in measured wrinkle depth after eight weeks is consistent with new collagen. It is equally consistent with skin simply holding more water, since swollen tissue reads as smoother on every one of these instruments. It is consistent with the base cream doing the work irrespective of the peptide dissolved in it, with participants staying out of the sun for a study they enrolled in, and with the ordinary drift back towards average that follows recruiting people at their worst. Without a comparison against the identical formulation minus the peptide, the mechanism remains a hypothesis wearing a result's clothing.

A study finding nothing is also far less likely to be written up when the sponsor sells the ingredient it examined, so what reaches print is not a random sample of what was run.

The one per cent line

If you take one practical thing from this piece, take this. Cosmetic ingredient lists are ordered by descending concentration — but only down to one per cent. Below that threshold the ordering requirement stops and the remaining ingredients may be listed in any sequence the manufacturer prefers. Peptides in cosmetics are used at levels comfortably underneath that line.

So past the one per cent point, the position of a peptide carries no quantity information whatsoever. You can locate that point roughly, since preservatives, fragrance components and colourants are conventional landmarks present in small amounts; anything among or after them is in the free zone. A peptide printed in large type on the front of a package may appear twenty-eighth in a list of thirty, at a level nobody has studied, and the label is entirely accurate.

Compounding this, peptide raw materials usually reach formulators already dissolved — a trade solution mostly of water and a humectant, the peptide a small fraction of that. When the list names the solution rather than the molecule, the actual peptide content is a fraction of a fraction. None of this is deception; the convention exists to identify what is in a product for safety purposes, not to let anyone reverse-engineer a formula. But it does mean "contains" is a statement about presence and nothing else.

• A list does tell you which peptide is present, under its standardised chemical name — the most useful fact on the pack, because it is the only one specific enough to look up.
• It tells you roughly where the one per cent boundary falls, using preservatives and colourants as landmarks.
• It does not tell you the concentration of anything below that boundary.
• It does not tell you whether the peptide is supplied neat or pre-diluted in a carrier.
• It does not tell you whether the level used resembles that in any published study.
• It does not tell you whether the formulation delivers the molecule past the outermost layer.

What the word is doing

None of this adds up to a debunking, and it would be dishonest to let it read as one. Some of these ingredients probably do something modest. The signal-peptide reasoning is mechanistically sensible and has cell-culture support 1; the copper-peptide literature is genuinely large and genuinely mechanistic 3; some products certainly contain these molecules at levels resembling those in studies. And a well-made cream improves the look of skin regardless — which is the outcome the category is permitted to promise in the first place.

But notice where the certainty sits. "Contains peptides" is a claim about chemistry: verifiable, checkable, and perfectly compatible with any level of efficacy at all, including none. It is the same grammatical form as "contains water". The implication travelling alongside it — that something is being done to your skin at the level of its biology — does all the persuasive work, and does it unstated.

In this the word behaves almost exactly like "natural". Both carry more meaning than they contain, and both survive scrutiny because the extra meaning is never spoken. What is unusual here is that the unspoken part is not unspoken by choice: it is the specific claim the regulatory framework forbids anyone from making outright. The pack gestures towards it, the law prevents the sentence being finished, and the reader finishes it themselves — an efficient arrangement for everybody except the person holding the jar.

The defensible position is neither that peptides in skincare are a con nor that they rebuild the dermis. It is that a category of real chemistry has been handed a marketing job no evidence available to it can discharge, and that the only honest way through the aisle is to stop reading the front of a package as though it were an evidence claim. It was never permitted to be one.